Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan
Abstract:
Castleman disease is a polyclonal lymphoproliferative disease which is clinically classified into unicentric (UCD) and multicentric (MCD). TAFRO syndrome is a relatively new concept that partly overlaps with MCD. Due to their rarity, their incidence remains unknown. This study investigated the incidence and prevalence of UCD, MCD, and TAFRO syndrome in Japan using a fixed-point observation method based on their incidence in Ishikawa prefecture. The annual incidences of MCD, UCD, and TAFRO syndrome in Japan were 309-731, 71-542, and 110-502, respectively, yielding annual incidence rates per million individuals of 2.4-5.8, 0.6-4.3, and 0.9-4.9, respectively, and nationwide prevalence of 4,180-14,900, 1,350-10,300, and 860-7,240, respectively. In conclusion, MCD, UCD and TAFRO syndrome may not be as rare as previously estimated in Japan.
Insights
Castleman disease (UCD, MCD) and TAFRO syndrome may be more common in Japan than previously thought. This study estimated their incidence and prevalence, suggesting they are not as rare as once believed.
Area of Science:
- Hematology
- Oncology
- Epidemiology
Background:
- Castleman disease, a polyclonal lymphoproliferative disorder, is classified into unicentric (UCD) and multicentric (MCD) forms.
- TAFRO syndrome is a recently described condition with clinical overlap with MCD.
- The true incidence and prevalence of these rare conditions remain largely unknown.
Purpose of the Study:
- To investigate the incidence and prevalence of UCD, MCD, and TAFRO syndrome in Japan.
- To provide updated epidemiological data for these rare lymphoproliferative disorders.
Main Methods:
- A fixed-point observation method was employed.
- Data were collected based on the incidence observed in Ishikawa prefecture, Japan.
- Calculations were extrapolated to estimate nationwide incidence and prevalence.
Main Results:
- Estimated annual incidences per million individuals: MCD (2.4-5.8), UCD (0.6-4.3), and TAFRO syndrome (0.9-4.9).
- Estimated nationwide prevalence ranges: MCD (4,180-14,900), UCD (1,350-10,300), and TAFRO syndrome (860-7,240).
- These findings suggest higher occurrence rates than previously assumed.
Conclusions:
- Castleman disease (UCD, MCD) and TAFRO syndrome may not be as rare in Japan as previously estimated.
- The study provides crucial epidemiological insights into these rare hematologic conditions.
More Related Videos
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Bias in Epidemiological Studies
Case Studies
